Accord Medical Clinic – Singapore
A gut hormone that reduces appetite and is being developed as a new injectable treatment for obesity.
Oxyntomodulin is a naturally occurring gut hormone that reduces appetite and helps control blood sugar. Scientists are developing it into an injectable medication for obesity. It works in a similar way to the GLP-1 medicines that are already widely used.
Oxyntomodulin is a peptide hormone co-secreted with GLP-1 from intestinal L-cells that acts as a dual agonist of the GLP-1 and glucagon receptors. It suppresses appetite, delays gastric emptying and increases energy expenditure through glucagon receptor agonism. Pharmaceutical analogues are under investigation for obesity, with early trials showing clinically meaningful weight loss.
New medications that act on multiple hormone pathways are expanding the options for treating obesity. Accord Medical Clinic stays current with these advances so we can offer you the most effective, evidence-based treatments available.
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for medical concerns. Accord Medical Clinic Singapore is an MOH-registered medical clinic in Singapore. Dr Joseph Wang (Family Physician) provides medical weight management consultations.